The Beauty Health Company (FRA:V7A0)

Market Cap	101.73M -47.0%
Revenue (ttm)	257.32M -13.1%
Net Income	-10.01M
EPS	-0.15
Shares Out	n/a
PE Ratio	n/a
Forward PE	85.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3
Open	0.7950
Previous Close	0.8250
Day's Range	0.7850 - 0.8250
52-Week Range	0.6800 - 2.2000
Beta	n/a
RSI	18.77
Earnings Date	Mar 13, 2026

About The Beauty Health Company

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1997
• Employees: 769
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: V7A0

Financial Performance

In 2024, The Beauty Health Company's revenue was $334.29 million, a decrease of -16.00% compared to the previous year's $397.99 million. Losses were -$29.10 million, -70.94% less than in 2023.

Financial numbers in USD